DOW INC
For the period ended Dec 31, 2024. Filed Feb 4, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 4, 2025
DOW$31.48+1.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Equity
| (In millions, except per share amounts) For the years ended Dec 31, | 2024 | 2023 | 2022 |
|---|---|---|---|
| Common Stock | |||
| Balance at beginning and end of year | $— | $— | $— |
| Additional Paid-in Capital | |||
| Balance at beginning of year | 9,091 | 8,627 | 8,159 |
| Issuance of parent company stock - Dow Inc. | 166 | 188 | 212 |
| Stock-based compensation and allocation of ESOP shares | 370 | 276 | 258 |
| Other | (1) | — | (2) |
| Balance at end of year | 9,626 | 9,091 | 8,627 |
| Retained Earnings | |||
| Balance at beginning of year | 17,495 | 19,472 | 19,288 |
| Net income available for The Dow Chemical Company's common stockholder | 1,127 | 556 | 4,583 |
| Dividends to Dow Inc. | (2,578) | (2,510) | (4,375) |
| Other | (24) | (23) | (24) |
| Balance at end of year | 16,020 | 17,495 | 19,472 |
| Accumulated Other Comprehensive Loss | |||
| Balance at beginning of year | (7,681) | (7,139) | (8,977) |
| Other comprehensive income (loss) | (429) | (542) | 1,838 |
| Balance at end of year | (8,110) | (7,681) | (7,139) |
| Unearned ESOP Shares | |||
| Balance at beginning of year | — | — | (15) |
| Allocation of ESOP shares | — | — | 15 |
| Balance at end of year | — | — | — |
| The Dow Chemical Company's stockholder's equity | 17,536 | 18,905 | 20,960 |
| Noncontrolling Interests | 496 | 501 | 529 |
| Total Equity | $18,032 | $19,406 | $21,489 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.